BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31151449)

  • 1. Development of a patient reported outcome measures for measuring the impact of visual impairment following stroke.
    Hepworth LR; Rowe FJ; Burnside G
    BMC Health Serv Res; 2019 May; 19(1):348. PubMed ID: 31151449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Delphi methodology in the development of a new patient-reported outcome measure for stroke survivors with visual impairment.
    Hepworth LR; Rowe FJ
    Brain Behav; 2018 Feb; 8(2):e00898. PubMed ID: 29484260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the brain injury associated visual impairment - impact questionnaire (BIVI-IQ).
    Hepworth LR; Kirkham JJ; Perkins E; Helliwell B; Howard C; Liptrot M; Tawana S; Wilson E; Rowe FJ
    Qual Life Res; 2024 Mar; 33(3):777-791. PubMed ID: 38112864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient reported outcome measures for visual impairment after stroke: a systematic review.
    Hepworth LR; Rowe FJ; Harper R; Jarvis K; Shipman T; Rodgers H
    Health Qual Life Outcomes; 2015 Sep; 13():146. PubMed ID: 26374628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of the Norwegian Fatigue Characteristics and Interference Measure (FCIM) for stroke survivors: cognitive interviews and Rasch analysis.
    Skogestad IJ; Kottorp A; Larsson P; Moen TM; Gay CL; Borge CR; Lerdal A
    Qual Life Res; 2023 Dec; 32(12):3389-3401. PubMed ID: 37468806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of the Child Amblyopia Treatment Questionnaire (CAT-QoL) using Rasch analysis.
    Carlton J
    Strabismus; 2019 Jun; 27(2):66-77. PubMed ID: 31012391
    [No Abstract]   [Full Text] [Related]  

  • 7. An Age- and Stage-Appropriate Patient-Reported Outcome Measure of Vision-Related Quality of Life of Children and Young People with Visual Impairment.
    Tadić V; Robertson AO; Cortina-Borja M; Rahi JS;
    Ophthalmology; 2020 Feb; 127(2):249-260. PubMed ID: 31623869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of a short version of Lee Fatigue Scale used as a generic PROM in persons with stroke or osteoarthritis: assessment using a Rasch analysis approach.
    Bragstad LK; Lerdal A; Gay CL; Kirkevold M; Lee KA; Lindberg MF; Skogestad IJ; Hjelle EG; Sveen U; Kottorp A
    Health Qual Life Outcomes; 2020 Jun; 18(1):168. PubMed ID: 32503548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the functional vision questionnaire for children and young people with visual impairment: the FVQ_CYP.
    Tadić V; Cooper A; Cumberland P; Lewando-Hundt G; Rahi JS;
    Ophthalmology; 2013 Dec; 120(12):2725-2732. PubMed ID: 24120327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke Specific Quality of Life Scale: Danish adaptation and a pilot study for testing psychometric properties.
    Muus I; Ringsberg KC
    Scand J Caring Sci; 2005 Jun; 19(2):140-7. PubMed ID: 15877639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing Item Banks for Measuring Quality of Life in Refractive Error.
    Kandel H; Khadka J; Fenwick EK; Shrestha MK; Sharma S; Sharma B; Kafle K; Kharal A; Kaiti R; Dhungana P; Nepal BP; Thapa S; Lamoureux E; Pesudovs K
    Optom Vis Sci; 2018 Jul; 95(7):575-587. PubMed ID: 29957741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of core outcome sets for vision screening and assessment in stroke: a Delphi and consensus study.
    Rowe FJ; Hepworth LR; Kirkham JJ
    BMJ Open; 2019 Sep; 9(9):e029578. PubMed ID: 31501115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the Vision Impairment in Low Luminance Questionnaire.
    Pondorfer SG; Terheyden JH; Overhoff H; Stasch-Bouws J; Holz FG; Finger RP
    Transl Vis Sci Technol; 2021 Jan; 10(1):5. PubMed ID: 33505772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papua New Guinea vision-specific quality of life questionnaire: a new patient-reported outcome instrument to assess the impact of impaired vision.
    Paudel P; Khadka J; Burnett A; Hani Y; Naduvilath T; Fricke TR
    Clin Exp Ophthalmol; 2015 Apr; 43(3):202-13. PubMed ID: 25132289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of core outcome sets and core outcome measures for central visual impairment, visual field loss and ocular motility disorders due to stroke: a Delphi and consensus study.
    Rowe FJ; Hepworth LR; Kirkham JJ
    BMJ Open; 2022 Mar; 12(3):e056792. PubMed ID: 35304397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale.
    Duncan PW; Bode RK; Min Lai S; Perera S;
    Arch Phys Med Rehabil; 2003 Jul; 84(7):950-63. PubMed ID: 12881816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary Stones and Intervention Quality of Life (USIQoL): Development and Validation of a New Core Universal Patient-reported Outcome Measure for Urinary Calculi.
    Joshi HB; Johnson H; Pietropaolo A; Raja A; Joyce AD; Somani B; Philip J; Biyani CS; Pickles T
    Eur Urol Focus; 2022 Jan; 8(1):283-290. PubMed ID: 33423970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the psychometric properties and refinement of the Health and Self-Management in Diabetes Questionnaire (HASMID).
    Carlton J; Rowen D; Elliott J
    Health Qual Life Outcomes; 2020 Mar; 18(1):59. PubMed ID: 32138742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening methods for post-stroke visual impairment: a systematic review.
    Hanna KL; Hepworth LR; Rowe F
    Disabil Rehabil; 2017 Dec; 39(25):2531-2543. PubMed ID: 27669628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.